Results 21 to 30 of about 13,559 (225)

Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance

Haematologica, 2010
Background Tumor cells in chronic lymphocytic leukemia accumulate in the periphery through the proliferation of a minority of cells in lymph nodes.
Rachel E. Hayden, Guy Pratt, Mark T. Drayson, Chris M. Bunce   +3 more
doaj   +1 more source

Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients

National Journal of Physiology, Pharmacy and Pharmacology, 2023
Background: Contraception is the intentional use of artificial methods or other techniques to prevent pregnancy as a consequence of sexual intercourse. Progesterone only injectables are highly effective in preventing in pregnancy as they do not rely on ...
Jayun M Joshi, Harsh M Joshi, Hetal Patel, Param S Patel   +3 more
doaj   +1 more source

Depot medroxyprogesterone acetate and breast cancer: a systematic review. [PDF]

Arch Gynecol Obstet
PURPOSE Short-acting progestin-only injectables containing depot medroxyprogesterone acetate (DMPA) are a safe method of contraception. Although DMPA has been available for several decades, there is little data on its influence on the risk of breast ...
Zürcher A, Knabben L, von Gernler M, Stute P.   +3 more
europepmc   +2 more sources

Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells [PDF]

, 2021
This document is the Accepted Manuscript version of a published work that appeared in final form in Bioscience Reports. To access the final edited and published work see http://dx.doi.org/10.1042/BSR20202505Drug repurposing is a cost effective means of ...
Ellington, Max A., Snow, Martyn D., Johnson, William E. B., Johnson, William E., Farhat, Khanim L., Southam, Andrew D., Bunce, Christopher M., Sheard, Jonathan J., Khanim, Farhat L., MacKay, Hannah L.   +9 more
core   +1 more source

Subcutaneous depo-medroxyprogesterone acetate [PDF]

Journal of Family Planning and Reproductive Health Care, 2013
Since 2004, a micronised formulation of depo-medroxyprogesterone acetate (DMPA) that is delivered as a subcutaneous injection has been available. It is currently in clinical use in the USA and in nine countries throughout Europe.1 As of March 2013 this product is being marketed in the UK as Sayana® Press (Pfizer, UK).
openaire   +2 more sources

Combined high dose vitamin C and E increases oxidative stress and visceral fat mass in rats treated by depot-medroxyprogesterone acetate

Middle East Fertility Society Journal, 2016
Objective: This study was aimed to investigate the effect of combined vitamin C and E on serum leptin, visceral fat mass, and visceral fat oxidative stress in rats treated by depot-medroxyprogesterone acetate (DMPA).
Endang Sri Wahyuni, I. Wayan Arsana Wiyasa, Nurdiana Nurdiana   +2 more
doaj   +1 more source

Potential Deleterious Effects Following the First Dose of Medroxyprogesterone Acetate as a Contraceptive in Cats [PDF]

Journal of Applied Veterinary Sciences, 2023
The aim of the present work was to investigate the deleterious effects of the first dose of medroxyprogesterone acetate (MPA) on the female genital system of cats.
Ahmed Abdelgalil
doaj   +1 more source

Effects of medroxyprogesterone acetate on gestation in mink [PDF]

Reproduction, 1982
Summary. Mink ovariectomized 14 days after the first of two matings received injections of 2 mg MPA, the same MPA treatment + an oestradiol-17β implant or no replacement therapy. Some mink were ovariectomized after implantation and given a single dose of 2 mg MPA or no replacement therapy.
B D, Murphy, P W, Concannon, H F, Travis
openaire   +2 more sources

The effect of Vigna unguiculata on the estrogen receptor-α expression and the endometrial thickness in rats treated with depot medroxyprogesterone acetate (DMPA)

Healthcare in Low-resource Settings, 2023
Depot medroxyprogesterone acetate (DMPA) is a contraceptive method that prevents ovulation and reduces endometrial thickness. This study aimed to investigate the influence of Vigna unguiculata (VU) on estrogen receptor-α expression and endometrial ...
Rizki Fitrianingtyas, Indah Christiana, Ririn Handayani, Ernawati Anggraeni, Zaida Mauludiyah, Sholihatil Hidayati   +5 more
doaj   +1 more source

Bone mineral density changes during use of progestin-only contraceptives: a rapid review of recent evidenceAJOG Global Reports at a Glance

AJOG Global Reports
Objective: The purpose of this paper is to consolidate existing evidence and identify knowledge and research gaps on the bone health effects of progestin-only oral contraception, injectables, hormonal intrauterine devices, and implants.
Blake Erhardt-Ohren, MPH, Ndola Prata, MD, MSc, Scott Rosenblum, MS   +2 more
doaj   +1 more source